Bain Capital Life Sciences Fund, L.P.

Overview

• HeadquartersGeorge Town, Cayman Islands²
• Legal formlimited partnership²
• Kind of organizationLimited partnership²
• LEI54930068UT0Q4M574X82²
• StatusActive²
• LEI statusIssued and current²
• Registered addressPO Box 309, KY1-1104 George Town, Cayman Islands²
• Registered withGeneral Registry, MC-87418²

See how the biggest companies compare on our leaderboards

Corporate structure

Bain Capital Life Sciences Fund, L.P. sits at the top of its group. 7 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); stakes of 5% or more it reported on Schedules 13D and 13G (6 companies). Each entity in the chart links to its source.

Timeline

1. Oct 8, 2016Founded Bain Capital Life Sciences Fund, L.P. is founded²

Filings

19 filings to the SEC since October 2021: 19 other. The latest 19:

1. Nov 14, 202513F-NT EDGAR
2. Aug 29, 2025N-PX EDGAR
3. Aug 14, 202513F-NT EDGAR
4. May 15, 202513F-NT EDGAR
5. Feb 14, 202513F-NT EDGAR
6. Nov 14, 202413F-NT EDGAR
7. Aug 30, 2024N-PX EDGAR
8. Aug 12, 202413F-NT EDGAR
9. May 15, 202413F-NT EDGAR
10. Feb 13, 202413F-NT EDGAR
11. Nov 14, 202313F-NT EDGAR
12. Aug 14, 202313F-NT EDGAR
13. May 15, 202313F-NT EDGAR
14. Feb 14, 202313F-NT EDGAR
15. Nov 14, 202213F-NT EDGAR
16. Aug 15, 202213F-NT EDGAR
17. May 16, 202213F-NT EDGAR
18. Feb 14, 202213F-NT EDGAR
19. Nov 15, 202113F-NT EDGAR

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Stakes it holds

Bain Capital Life Sciences Fund, L.P. has told the SEC it owns more than 5% of 6 companies, latest first (Schedules 13D and 13G).

• RAPID MICRO BIOSYSTEMS, INC.SCHEDULE 13G/A Feb 14, 2022 to Aug 14, 2026³
• Pharvaris N.V.SCHEDULE 13G/A Jun 23, 2023 to Feb 17, 2026⁴
• X4 Pharmaceuticals, IncSCHEDULE 13G/A Feb 14, 2022 to Feb 17, 2026⁵
• Annexon, Inc.SCHEDULE 13G/A Feb 14, 2023 to Feb 14, 2025⁶
• DYNAVAX TECHNOLOGIES CORPSC 13D/A Aug 17, 2022⁷
• Arcutis Biotherapeutics, Inc.SC 13D/A May 27, 2022 to Aug 8, 2022⁸